Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder

Human Pathology

Volumn 40, Issue 1, 2009, Pages 108-116

  Thomas, Anil A ^a   Stephenson, Andrew J ^a,b   Campbell, Steven C ^a,b   Jones, J Stephen ^a   Hansel, Donna E ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Bladder neoplasms; Clinicopathologic; Cystectomy; Immunohistochemistry; Signet ring cell carcinoma; Treatment outcome; Urachus

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MORPHOLOGY; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SIGNET RING CELL; COLONIC NEOPLASMS; CYSTECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 56249123231     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.06.022     Document Type: Article

References (34)

1. Jacobo E., Loening S., Schmidt J.D., and Culp D.A. Primary adenocarcinoma of the bladder: a retrospective study of 20 patients. J Urol 117 (1977) 54-56
2. Thomas D.G., Ward A.M., and Williams J.L. A study of 52 cases of adenocarcinoma of the bladder. Br J Urol 43 (1971) 4-15
3. Wright J.L., Porter M.P., Li C.I., Lange P.H., and Lin D.W. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 107 (2006) 721-728
4. Dandekar N.P., Dalal A.V., Tongaonkar H.B., and Kamat M.R. Adenocarcinoma of bladder. Eur J Surg Oncol 23 (1997) 157-160
5. Grignon D.J., Ro J.Y., Ayala A.G., Johnson D.E., and Ordonez N.G. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer 67 (1991) 2165-2172
6. el-Mekresh M.M., el-Baz M.A., Abol-Enein H., and Ghoneim M.A. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol 82 (1998) 206-212
7. Susmano D., Rubenstein A.B., Dakin A.R., and Lloyd F.A. Cystitis glandularis and adenocarcinoma of the bladder. J Urol 105 (1971) 671-674
8. Bullock P.S., Thoni D.E., and Murphy W.M. The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer 59 (1987) 2086-2090
9. Corica F.A., Husmann D.A., Churchill B.M., et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology 50 (1997) 427-431
10. Seibel J.L., Prasad S., Weiss R.E., Bancila E., and Epstein J.I. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy. Hum Pathol 33 (2002) 236-241
11. Grignon D.J., Ro J.Y., Ayala A.G., and Johnson D.E. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 95 (1991) 13-20
12. Blute M.L., Engen D.E., Travis W.D., and Kvols L.K. Primary signet ring cell adenocarcinoma of the bladder. J Urol 141 (1989) 17-21
13. Chor P.J., Gaum L.D., and Young R.H. Clear cell adenocarcinoma of the urinary bladder: report of a case of probable mullerian origin. Mod Pathol 6 (1993) 225-228
14. Young R.H., and Scully R.E. Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol 9 (1985) 816-826
15. Burgues O., Ferrer J., Navarro S., Ramos D., Botella E., and Llombart-Bosch A. Hepatoid adenocarcinoma of the urinary bladder. An unusual neoplasm. Virchows Arch 435 (1999) 71-75
16. Johnson D.E., Hodge G.B., Abdul-Karim F.W., and Ayala A.G. Urachal carcinoma. Urology 26 (1985) 218-221
17. Osunkoya A.O., and Epstein J.I. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases. Am J Surg Pathol 31 (2007) 1323-1329
18. Suh N., Yang X.J., Tretiakova M.S., Humphrey P.A., and Wang H.L. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 18 (2005) 1217-1222
19. Raspollini M.R., Nesi G., Baroni G., Girardi L.R., and Taddei G.L. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol 13 (2005) 358-362
20. Tamboli P., Mohsin S.K., Hailemariam S., and Amin M.B. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med 126 (2002) 1057-1063
21. Tsuta K., Ishii G., Nitadori J., et al. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. J Pathol 209 (2006) 78-87
22. Sheldon C.A., Clayman R.V., Gonzalez R., Williams R.D., and Fraley E.E. Malignant urachal lesions. J Urol 131 (1984) 1-8
23. Wang H.L., Lu D.W., Yerian L.M., et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 25 (2001) 1380-1387
24. Chu P.G., and Weiss L.M. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 121 (2004) 884-892
25. Guo R.J., Suh E.R., and Lynch J.P. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 3 (2004) 593-601
26. Burnett A.L., Epstein J.I., and Marshall F.F. Adenocarcinoma of urinary bladder: classification and management. Urology 37 (1991) 315-321
27. Holmang S., Borghede G., and Johansson S.L. Primary signet ring cell carcinoma of the bladder: a report on 10 cases. Scand J Urol Nephrol 31 (1997) 145-148
28. Choi H., Lamb S., Pintar K., and Jacobs S.C. Primary signet-ring cell carcinoma of the urinary bladder. Cancer 53 (1984) 1985-1990
29. Xiaoxu L., Jianhong L., Jinfeng W., and Klotz L.H. Bladder adenocarcinoma: 31 reported cases. Can J Urol 8 (2001) 1380-1383
30. Moll R., Robine S., Dudouet B., and Louvard D. Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 54 (1987) 155-169
31. Debruyne P., Vermeulen S., and Mareel M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 62 (1999) 393-402
32. Takayama T., Shiozaki H., Shibamoto S., et al. Beta-catenin expression in human cancers. Am J Pathol 148 (1996) 39-46
33. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
34. Byrne R.R., Shariat S.F., Brown R., et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. J Urol 165 (2001) 1473-1479